These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 3160596)

  • 41. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
    Croci T; Landi M; Bianchetti A; Manara L
    Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
    Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of 5-hydroxytryptamine binding site subtypes in rat spinal cord.
    Huang JC; Peroutka SJ
    Brain Res; 1987 Dec; 436(1):173-6. PubMed ID: 2961414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
    Sharp T; Bramwell SR; Grahame-Smith DG
    Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y; Yamawaki S
    Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for 5-HT1A binding sites in chick embryo brain and discrimination by 5-methoxytryptamine.
    Soblosky JS; Dills C; DuMontier G; Jeng I
    Biochem Int; 1987 May; 14(5):797-803. PubMed ID: 2970262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC; Kitchen I
    Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypotensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin and 5-methylurapidil following stereotaxic microinjection into the ventral medulla of the rat.
    Valenta B; Singer EA
    Br J Pharmacol; 1990 Apr; 99(4):713-6. PubMed ID: 1972893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The guinea-pig ileum preparation as a model for 5-HT1A receptors: anomalous effects with RS-30199-193.
    Small C; Brown CM; Redfern WS; Spedding M
    Br J Pharmacol; 1991 Oct; 104(2):519-25. PubMed ID: 1839137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
    Waldmeier PC; Williams M; Baumann PA; Bischoff S; Sills MA; Neale RF
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):609-20. PubMed ID: 2905765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks.
    Millan MJ; Bervoets K; Colpaert FC
    Neurosci Lett; 1989 Dec; 107(1-3):227-32. PubMed ID: 2533334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH; Beller KD; Kolassa N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.
    Winter JC; Petti DT
    Pharmacol Biochem Behav; 1987 Aug; 27(4):625-8. PubMed ID: 2958885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Species variations in RU 24969 interactions with non-5-HT1A binding sites.
    Heuring RE; Schlegel JR; Peroutka SJ
    Eur J Pharmacol; 1986 Mar; 122(2):279-82. PubMed ID: 2940097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.